Peregrine Pharma (PPHM) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Cost of contract manufacturing: 3.06M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of contract manufacturing: 3.06M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q2 loss of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $2.83 million versus the consensus estimate of $2.28 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
